Twin Capital Management Inc. bought a new stake in shares of Dolby Laboratories (NYSE:DLB – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 16,531 shares of the electronics maker’s stock, valued at approximately $993,000.
A number of other institutional investors and hedge funds have also bought and sold shares of the company. Illinois Municipal Retirement Fund grew its position in shares of Dolby Laboratories by 33.9% during the 1st quarter. Illinois Municipal Retirement Fund now owns 42,933 shares of the electronics maker’s stock worth $2,579,000 after buying an additional 10,871 shares in the last quarter. Signet Financial Management LLC bought a new stake in shares of Dolby Laboratories in the first quarter valued at about $231,000. Sanctuary Advisors LLC lifted its stake in Dolby Laboratories by 8.9% in the first quarter. Sanctuary Advisors LLC now owns 8,022 shares of the electronics maker’s stock worth $482,000 after acquiring an additional 657 shares during the period. State of Michigan Retirement System lifted its stake in Dolby Laboratories by 1.4% in the first quarter. State of Michigan Retirement System now owns 14,700 shares of the electronics maker’s stock worth $883,000 after acquiring an additional 200 shares during the period. Finally, Principal Financial Group Inc. lifted its stake in Dolby Laboratories by 3.3% in the first quarter. Principal Financial Group Inc. now owns 135,936 shares of the electronics maker’s stock worth $8,164,000 after acquiring an additional 4,371 shares during the period. 58.56% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
DLB has been the topic of a number of research reports. Barrington Research reissued an “outperform” rating and set a $90.00 target price on shares of Dolby Laboratories in a research report on Monday, June 15th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Wednesday, June 24th. Wall Street Zen upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Finally, Rosenblatt Securities reissued a “buy” rating and set a $85.00 price objective on shares of Dolby Laboratories in a report on Thursday, June 11th. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, Dolby Laboratories has an average rating of “Moderate Buy” and a consensus price target of $90.75.
Dolby Laboratories Stock Up 1.7%
NYSE DLB opened at $49.99 on Friday. The firm has a market cap of $4.73 billion, a PE ratio of 19.76 and a beta of 0.81. The company has a 50 day moving average price of $53.10 and a 200 day moving average price of $59.55. Dolby Laboratories has a 52 week low of $48.26 and a 52 week high of $77.00.
Dolby Laboratories (NYSE:DLB – Get Free Report) last announced its earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.31 by $0.06. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The company had revenue of $395.63 million during the quarter, compared to the consensus estimate of $385.80 million. During the same period last year, the firm earned $1.34 earnings per share. Dolby Laboratories’s revenue was up 7.0% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, equities research analysts anticipate that Dolby Laboratories will post 3.21 earnings per share for the current fiscal year.
Dolby Laboratories Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were given a $0.36 dividend. The ex-dividend date of this dividend was Tuesday, May 12th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.9%. Dolby Laboratories’s dividend payout ratio (DPR) is presently 56.92%.
Insiders Place Their Bets
In other Dolby Laboratories news, CMO Todd Pendleton sold 11,876 shares of the stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $54.55, for a total value of $647,835.80. Following the completion of the sale, the chief marketing officer directly owned 41,480 shares in the company, valued at approximately $2,262,734. This trade represents a 22.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Shriram Revankar sold 3,000 shares of the firm’s stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $54.90, for a total value of $164,700.00. Following the completion of the sale, the senior vice president directly owned 80,603 shares of the company’s stock, valued at approximately $4,425,104.70. This represents a 3.59% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 47,458 shares of company stock valued at $2,639,537 in the last 90 days. Corporate insiders own 37.93% of the company’s stock.
About Dolby Laboratories
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Featured Stories
- Five stocks we like better than Dolby Laboratories
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
